Table 1. Baseline characteristics of study population by gender.
Gender | |||
Women (n = 745) | Men (n = 2897) | p-value | |
Baseline clinical indicators | |||
Baseline CD4 cell count (cells/mm3) | |||
Median | 210 | 200 | p<0.001 |
Interquartile Range | 130–310 | 100–300 | |
Baseline plasma viral load (log10 copies/mL) | |||
Median | 4.8 | 4.9 | p<0.001 |
Interquartile Range | 4.1–5.0 | 4.5–5.0 | |
Patient characteristics | |||
Age | |||
Median | 36 | 42 | <0.001 |
Interquartile Range | 30–44 | 36–49 | |
Aboriginal ancestry, n (%) | |||
No | 216 (29) | 1143 (39) | <0.001 |
Yes | 188 (25) | 247 (9) | |
Unknown | 341 (46) | 1507 (52) | |
History of IDU, n (%) | |||
No | 243 (33) | 1342 (46) | <0.001 |
Yes | 432 (58) | 954 (33) | |
Unknown | 70 (9) | 601 (21) | |
System characteristics | |||
Prescriber experience (HIV patient caseload) | |||
Median | 96 | 108 | <0.001 |
Interquartile Range | 18–204 | 24–266 | |
Place of residence at baseline, n (%) | |||
Fraser | 191 (26) | 575 (20) | <0.001 |
Interior + Northern | 118 (16) | 237 (8) | |
Vancouver Island | 103 (14) | 311 (11) | |
Vancouver Coastal | 328 (44) | 1766 (61) | |
Year HAART was initiated, n (%) | |||
2000–2003 | 234 (31) | 874 (30) | 0.552 |
2004–2007 | 271 (37) | 1029 (36) | |
2008–2010 | 240 (32) | 994 (34) |